These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15578221)

  • 1. Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors.
    Steverding D; Spackman RW; Royle HJ; Glenn RJ
    Parasitol Res; 2005 Jan; 95(1):73-6. PubMed ID: 15578221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanocidal effect of alpha',beta'-epoxyketones indicates that trypanosomes are particularly sensitive to inhibitors of proteasome trypsin-like activity.
    Glenn RJ; Pemberton AJ; Royle HJ; Spackman RW; Smith E; Jennifer Rivett A; Steverding D
    Int J Antimicrob Agents; 2004 Sep; 24(3):286-9. PubMed ID: 15325434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma brucei: β2-selective proteasome inhibitors do not block the proteasomal trypsin-like activity but are trypanocidal.
    Steverding D; Florea BI; Overkleeft HS
    Mol Biochem Parasitol; 2019 Jan; 227():1-4. PubMed ID: 30444977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity.
    Steverding D; Baldisserotto A; Wang X; Marastoni M
    Exp Parasitol; 2011 Aug; 128(4):444-7. PubMed ID: 21458452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors.
    Steverding D; Wang X; Potts BC; Palladino MA
    Planta Med; 2012 Jan; 78(2):131-4. PubMed ID: 22034066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the anti-trypanosomal activity of tyropeptin A.
    Steverding D; Pemberton AJ; Royle H; Spackman RW; Rivett AJ
    Planta Med; 2006 Jun; 72(8):761-3. PubMed ID: 16732530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinyl sulfone-based peptidomimetics as anti-trypanosomal agents: design, synthesis, biological and computational evaluation.
    Dunny E; Doherty W; Evans P; Malthouse JP; Nolan D; Knox AJ
    J Med Chem; 2013 Sep; 56(17):6638-50. PubMed ID: 23952916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and optimisation of P
    Doherty W; Adler N; Butler TJ; Knox AJS; Evans P
    Bioorg Med Chem; 2020 Dec; 28(23):115774. PubMed ID: 32992251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, anti-trypanosomal activity and localisation of a series of dipeptide-based vinyl sulfones.
    Doherty W; James J; Evans P; Martin L; Adler N; Nolan D; Knox A
    Org Biomol Chem; 2014 Oct; 12(38):7561-71. PubMed ID: 25137249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma brucei: Inhibition of cathepsin L is sufficient to kill bloodstream forms.
    Steverding D; Rushworth SA; Florea BI; Overkleeft HS
    Mol Biochem Parasitol; 2020 Jan; 235():111246. PubMed ID: 31743688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new reporter cell line for studies with proteasome inhibitors in Trypanosoma brucei.
    Moura DMN; de Melo Neto OP; Carrington M
    Mol Biochem Parasitol; 2019 Jan; 227():15-18. PubMed ID: 30444978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitrypanosomal activities of proteasome inhibitors.
    Nkemngu NJ; Rosenkranz V; Wink M; Steverding D
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2038-40. PubMed ID: 12019136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors.
    Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M
    ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved trypanocidal activities of cathepsin L inhibitors.
    Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D
    Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
    Merschjohann K; Steverding D
    Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors.
    Steverding D
    Exp Parasitol; 2015; 151-152():28-33. PubMed ID: 25662707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
    Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
    Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of salinomycin and monensin derivatives against Trypanosoma brucei.
    Steverding D; Antoszczak M; Huczyński A
    Parasit Vectors; 2016 Jul; 9(1):409. PubMed ID: 27457761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanocidal activity of tetradentated pyridine-based manganese complexes is not linked to inactivation of superoxide dismutase.
    Steverding D; Kolosevska K; Sánchez-Moreno M
    Exp Parasitol; 2018 Sep; 192():1-5. PubMed ID: 30026114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.